Sibutramine hydrochloride is a medication that was created for the purpose of managing obesity by influencing serotonin and noradrenaline reuptake processes in the body. Initially introduced by Abbott Laboratories in the United States with the brand name Meridia in 1998 was following by FDA approval. While it may not offer results like some other medications do its primary benefit lies in facilitating sustained weight loss when paired with a reduced calorie diet. Despite its proven effects it was taken off the market in the U.S. in 2010 due, to concerns regarding cardiovascular risks.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For more details consult with your doctor or healthcare professional.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.